Levosimendan, a new therapeutic approach to prevent delayed cerebral vasospasm after subarachnoid hemorrhage?
about
Crosstalk between the angiotensin and endothelin system in the cerebrovasculature after experimental induced subarachnoid hemorrhage.Vasomodulatory effects of the angiotensin II type 1 receptor antagonist losartan on experimentally induced cerebral vasospasm after subarachnoid haemorrhage.Use of levosimendan in the treatment of cerebral vascular vasospasm: a case study.
P2860
Levosimendan, a new therapeutic approach to prevent delayed cerebral vasospasm after subarachnoid hemorrhage?
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Levosimendan, a new therapeuti ...... after subarachnoid hemorrhage?
@en
Levosimendan, a new therapeuti ...... after subarachnoid hemorrhage?
@nl
type
label
Levosimendan, a new therapeuti ...... after subarachnoid hemorrhage?
@en
Levosimendan, a new therapeuti ...... after subarachnoid hemorrhage?
@nl
prefLabel
Levosimendan, a new therapeuti ...... after subarachnoid hemorrhage?
@en
Levosimendan, a new therapeuti ...... after subarachnoid hemorrhage?
@nl
P2093
P2860
P1433
P1476
Levosimendan, a new therapeuti ...... after subarachnoid hemorrhage?
@en
P2093
Erdem Gueresir
Hartmut Vatter
Jan Mrosek
Johannes Platz
Patrick Schuss
Stefan Wanderer
Volker Seifert
P2860
P2888
P304
P356
10.1007/S00701-016-2939-5
P577
2016-09-10T00:00:00Z